Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Tariff Impact
High Loss High Volume
|
Strong Performer, Under Radar
1105.3500
-71.00
(
-6.04
%)
NSE
Apr 04, 2025
15:31 PM
30.57% Fall from 52W High
Volume:
7.2M
High volume+loss today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
10 Feb 2025
Tariff Impact
High Loss High Volume
1105.35
-6.04%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1500 | Upside : 35.7%
Target
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,500/share
Aurobindo Pharma Ltd. has lost
-24.60%
in the last 6 Months
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - April 4, 2025
The Baseline |
04 Apr 2025, 06:15PM
Market closes lower, L&T Finance's loan book expands 18.8% YoY in Q4FY25
Trendlyne Marketwatch |
04 Apr 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020